Unique ID issued by UMIN | UMIN000043189 |
---|---|
Receipt number | R000049293 |
Scientific Title | Scale development and an educational program to reduce the stigma of schizophrenia among community pharmacists: a randomized controlled trial |
Date of disclosure of the study information | 2021/01/30 |
Last modified on | 2021/08/01 13:58:59 |
Scale development and an educational program to reduce the stigma of schizophrenia among community pharmacists: a randomized controlled trial
An educational program to reduce the stigma of schizophrenia among community pharmacists
Scale development and an educational program to reduce the stigma of schizophrenia among community pharmacists: a randomized controlled trial
An educational program to reduce the stigma of schizophrenia among community pharmacists
Japan |
General population
Adult |
Others
NO
This study aims to investigate that a combining the educational interventions based on lecture of schizophrenia and communication with patients improve the stigma toward people with schizophrenia among community pharmacists by using a newly developed Stigma Scale towards Schizophrenia for Community Pharmacists
Efficacy
The amount of change in the degree of stigma for schizophrenia patients before and after intervention by using the Stigma Scale towards Schizophrenia for Community Pharmacists
Interventional
Parallel
Randomized
Individual
Open -but assessor(s) are blinded
Active
YES
YES
2
Educational,Counseling,Training
Other |
A 60-minute communicating with patients with schizophrenia and a 60-minute lecture on schizophrenia
A 60-minute lecture on schizophrenia
25 | years-old | <= |
65 | years-old | > |
Male and Female
A community pharmacist with over a year of work experience as a pharmacist
A community pharmacist with less than a year of work experience as a pharmacist
A pharmacist who works outside the insurance pharmacy
120
1st name | Hiroyuki |
Middle name | |
Last name | Kamei |
Meijo University
Office of Clinical Pharmacy Practice and Health Care Management, Faculty of Pharmacy
468-8503
150 Yagotoyama, Tempaku-ku, Nagoya, Aichi
052-839-2643
hkamei@meijo-u.ac.jp
1st name | Hiroyuki |
Middle name | |
Last name | Kamei |
Meijo University
Office of Clinical Pharmacy Practice and Health Care Management, Faculty of Pharmacy
468-8503
150 Yagotoyama, Tempaku-ku, Nagoya, Aichi
052-839-2643
hkamei@meijo-u.ac.jp
Meijo University
Ministry of Education, Culture, Sports, Science and Technology
Japanese Governmental office
the Meijo University Research Ethics Board
1-501 Shiogamaguchi, Tempaku-ku, Nagoya, Aichi
0528382034
souken@ccml.meijo-u.ac.jp
NO
2021 | Year | 01 | Month | 30 | Day |
https://upload.umin.ac.jp/cgi-open-bin/ctr/ctr_view.cgi?recptno=R000049293
Unpublished
https://upload.umin.ac.jp/cgi-bin/icdr/ctr_up_reg_f5.cgi
115
Educational program-related changes of the median (interquartile range) total SSCP score from baseline were -9.0(-16.0- -5.0) in the contact-based intervention group and -3.0(-7.0- 1.0) in the educational lecture group, reflecting a significant reduction of stigma levels in the contact-based intervention group.
2021 | Year | 08 | Month | 01 | Day |
115 community pharmacists
Participants were individually allocated to two groups: educational lecture group (56; only attending a lecture on schizophrenia) or contact-based intervention group (59; communicating with patients diagnosed with schizophrenia and attending the lecture).
N/A
Stigma Scale towards Schizophrenia for Community Pharmacists (SSCP)
No longer recruiting
2018 | Year | 06 | Month | 01 | Day |
2018 | Year | 08 | Month | 22 | Day |
2019 | Year | 05 | Month | 13 | Day |
2020 | Year | 03 | Month | 31 | Day |
2021 | Year | 01 | Month | 30 | Day |
2021 | Year | 08 | Month | 01 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000049293
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |